Spots Global Cancer Trial Database for disseminated neuroblastoma
Every month we try and update this database with for disseminated neuroblastoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy in Treating Children With Neuroblastoma | NCT00003093 | Neuroblastoma | filgrastim sargramostim carboplatin cyclophosphamid... doxorubicin hyd... etoposide conventional su... neoadjuvant the... | - 20 Years | Children's Oncology Group | |
| Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma | NCT00006102 | Brain and Centr... Lymphoma Neuroblastoma Retinoblastoma Sarcoma Unspecified Chi... | becatecarin | - 21 Years | National Cancer Institute (NCI) | |
| Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation | NCT00003743 | Neuroblastoma | aldesleukin | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma | NCT00410631 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... conventional su... peripheral bloo... iobenguane I 13... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma | NCT00037011 | Neuroblastoma | beta-glucan monoclonal anti... | - 49 Years | Memorial Sloan Kettering Cancer Center | |
| Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00017225 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide ifosfamide melphalan tretinoin vincristine sul... vindesine autologous bone... conventional su... peripheral bloo... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00004188 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide isotretinoin melphalan topotecan hydro... vincristine sul... autologous bone... bone marrow abl... conventional su... peripheral bloo... radiation thera... | - 30 Years | Children's Oncology Group | |
| Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma | NCT01387724 | Neuroblastoma | RNA analysis polymerase chai... protein express... proteomic profi... western blottin... enzyme-linked i... immunohistochem... laboratory biom... liquid chromato... mass spectromet... | 1 Year - 10 Years | Children's Oncology Group | |
| N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma | NCT00093353 | Diarrhea Drug/Agent Toxi... Neuroblastoma | cefixime irinotecan hydr... temozolomide | 1 Year - 30 Years | Children's Hospital Los Angeles | |
| Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma | NCT00030719 | Neuroblastoma | filgrastim monoclonal anti... busulfan carboplatin cyclophosphamid... etoposide isotretinoin melphalan vincristine sul... bone marrow abl... conventional su... peripheral bloo... radiation thera... | 1 Year - 20 Years | National Cancer Institute (NCI) | |
| Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma | NCT01358617 | Disseminated Ne... Localized Resec... Localized Unres... Recurrent Neuro... Stage 4S Neurob... | diagnostic labo... | - | Children's Oncology Group | |
| Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma | NCT00450307 | Neuroblastoma | monoclonal anti... sargramostim | - 21 Years | Memorial Sloan Kettering Cancer Center | |
| Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma | NCT00392340 | Neuroblastoma | filgrastim doxorubicin hyd... topotecan hydro... vincristine sul... | 1 Year - 20 Years | National Cancer Institute (NCI) | |
| Studying Gene Expression in Samples From Younger Patients With Neuroblastoma | NCT01553448 | Neoplastic Synd... Neuroblastoma | gene expression... protein express... enzyme-linked i... immunohistochem... laboratory biom... medical chart r... | - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma | NCT00526318 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... iobenguane I 13... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation | NCT00003743 | Neuroblastoma | aldesleukin | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma | NCT00025649 | Neuroblastoma | filgrastim busulfan carboplatin cyclophosphamid... doxorubicin hyd... etoposide melphalan vincristine sul... autologous bone... conventional su... peripheral bloo... | - 1 Year | National Cancer Institute (NCI) | |
| Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment | NCT00089258 | Neuroblastoma | beta-glucan monoclonal anti... sargramostim isotretinoin | - | Memorial Sloan Kettering Cancer Center | |
| R(+)XK469 in Treating Patients With Advanced Neuroblastoma | NCT00028522 | Disseminated Ne... Localized Unres... Recurrent Neuro... Regional Neurob... | R(+)XK469 | 5 Years - 20 Years | National Cancer Institute (NCI) | |
| Study of DNA in Blood Samples From Patients With Neuroblastoma | NCT00898391 | Disseminated Ne... Localized Resec... Localized Unres... Recurrent Neuro... Regional Neurob... Stage 4S Neurob... | laboratory biom... polymerase chai... polyacrylamide ... DNA analysis | - | Children's Oncology Group | |
| Induction Chemotherapy Using Cyclophosphamide and Topotecan in Treating Patients Who Are Undergoing Autologous Peripheral Stem Cell Transplantation for Newly Diagnosed or Progressive Neuroblastoma | NCT00070200 | Neuroblastoma | filgrastim cisplatin cyclophosphamid... doxorubicin hyd... etoposide isotretinoin melphalan topotecan hydro... vincristine sul... conventional su... peripheral bloo... radiation thera... | - 30 Years | Children's Oncology Group | |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | NCT00003926 | Brain and Centr... Childhood Germ ... Chordoma Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Retinoblastoma Sarcoma | amifostine trih... busulfan filgrastim melphalan thiotepa peripheral bloo... | 1 Year - 45 Years | Masonic Cancer Center, University of Minnesota | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Children With Brain Tumors | NCT00281905 | Brain and Centr... Neuroblastoma | carboplatin cisplatin cyclophosphamid... methotrexate vincristine sul... radiation thera... | - 3 Years | National Cancer Institute (NCI) | |
| Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma | NCT00006480 | Neuroblastoma | aldesleukin therapeutic aut... chemotherapy ganciclovir | 1 Year - 17 Years | Fred Hutchinson Cancer Center | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma | NCT00017368 | Neuroblastoma | filgrastim sargramostim carboplatin cisplatin cyclophosphamid... doxorubicin hyd... etoposide etoposide phosp... ifosfamide isotretinoin melphalan thiotepa vincristine sul... conventional su... peripheral bloo... radiation thera... | - 30 Years | Children's Oncology Group | |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | NCT00003926 | Brain and Centr... Childhood Germ ... Chordoma Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Retinoblastoma Sarcoma | amifostine trih... busulfan filgrastim melphalan thiotepa peripheral bloo... | 1 Year - 45 Years | Masonic Cancer Center, University of Minnesota | |
| Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma | NCT00002634 | Neuroblastoma | filgrastim monoclonal anti... cisplatin cyclophosphamid... doxorubicin hyd... etoposide mesna perfosfamide vincristine sul... autologous bone... in vitro-treate... low-LET cobalt-... low-LET photon ... radioisotope th... | 1 Year - | Memorial Sloan Kettering Cancer Center | |
| Biomarkers in Young Patients With Neuroblastoma | NCT01169376 | Neuroblastoma | DNA analysis DNA methylation... RNA analysis comparative gen... mutation analys... polymorphism an... | - 30 Years | Children's Oncology Group | |
| Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma | NCT00392340 | Neuroblastoma | filgrastim doxorubicin hyd... topotecan hydro... vincristine sul... | 1 Year - 20 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma | NCT00030719 | Neuroblastoma | filgrastim monoclonal anti... busulfan carboplatin cyclophosphamid... etoposide isotretinoin melphalan vincristine sul... bone marrow abl... conventional su... peripheral bloo... radiation thera... | 1 Year - 20 Years | National Cancer Institute (NCI) | |
| N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma | NCT01019850 | Neuroblastoma | Vorinostat 131- I Metaiodo... Peripheral Bloo... Filgrastim | 2 Years - 30 Years | New Approaches to Neuroblastoma Therapy Consortium | |
| N99-01: Combination Chemotherapy, Radiation Therapy, and Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00005978 | Neuroblastoma | filgrastim carboplatin etoposide melphalan autologous bone... peripheral bloo... iobenguane I 13... radiation thera... | 1 Year - 21 Years | New Approaches to Neuroblastoma Therapy Consortium | |
| Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma | NCT00960739 | Neuroblastoma | Topotecan hydro... Autologous hema... iobenguane I 13... total-body irra... | 1 Year - 20 Years | Centre Oscar Lambret | |
| Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma | NCT00492167 | Neuroblastoma | beta-glucan monoclonal anti... immunohistochem... laboratory biom... | 0 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma | NCT00002740 | Neuroblastoma | filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide mesna vincristine sul... conventional su... peripheral bloo... low-LET cobalt-... low-LET photon ... | 1 Year - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma | NCT00025610 | Neuroblastoma | carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... | - 1 Year | National Cancer Institute (NCI) | |
| Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma | NCT00017225 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide ifosfamide melphalan tretinoin vincristine sul... vindesine autologous bone... conventional su... peripheral bloo... radiation thera... | - 20 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma | NCT00002740 | Neuroblastoma | filgrastim carboplatin cyclophosphamid... doxorubicin hyd... etoposide mesna vincristine sul... conventional su... peripheral bloo... low-LET cobalt-... low-LET photon ... | 1 Year - 21 Years | Children's Oncology Group | |
| Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma | NCT00492167 | Neuroblastoma | beta-glucan monoclonal anti... immunohistochem... laboratory biom... | 0 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment | NCT00089258 | Neuroblastoma | beta-glucan monoclonal anti... sargramostim isotretinoin | - | Memorial Sloan Kettering Cancer Center | |
| Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma | NCT02173093 | Disseminated Ne... Recurrent Neuro... | IL-2 GD2Bi-aATC GM-CSF laboratory eval... | 13 Months - 29 Years | University of Virginia | |
| Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma | NCT00037011 | Neuroblastoma | beta-glucan monoclonal anti... | - 49 Years | Memorial Sloan Kettering Cancer Center | |
| N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma | NCT01019850 | Neuroblastoma | Vorinostat 131- I Metaiodo... Peripheral Bloo... Filgrastim | 2 Years - 30 Years | New Approaches to Neuroblastoma Therapy Consortium | |
| Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma | NCT00006480 | Neuroblastoma | aldesleukin therapeutic aut... chemotherapy ganciclovir | 1 Year - 17 Years | Fred Hutchinson Cancer Center | |
| Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma | NCT00526318 | Neuroblastoma | filgrastim carboplatin cisplatin cyclophosphamid... dacarbazine doxorubicin hyd... etoposide phosp... ifosfamide isotretinoin melphalan topotecan hydro... vincristine sul... vindesine autologous hema... iobenguane I 13... radiation thera... | - 21 Years | National Cancer Institute (NCI) | |
| N99-02: Melphalan and Buthionine Sulfoximine | NCT00005835 | Neuroblastoma | buthionine sulf... melphalan Peripheral bloo... Filgrastim | - 30 Years | New Approaches to Neuroblastoma Therapy Consortium | |
| Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma | NCT00025610 | Neuroblastoma | carboplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... | - 1 Year | National Cancer Institute (NCI) | |
| Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma | NCT00072358 | Neuroblastoma | anti-GD2 murine... anti-GD2 murine... | - | Memorial Sloan Kettering Cancer Center | |
| Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer | NCT00060372 | Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Atypical Chroni... Childhood Myelo... Chronic Myeloge... Disseminated Ne... Malignant Neopl... Ovarian Chorioc... Ovarian Embryon... Ovarian Immatur... Ovarian Mature ... Ovarian Mixed G... Ovarian Monoder... Ovarian Polyemb... Ovarian Yolk Sa... Previously Trea... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Malig... Recurrent Mantl... Recurrent Neuro... Recurrent Ovari... Recurrent Ovari... Refractory Chro... Refractory Mult... Relapsing Chron... Stage I Multipl... Stage II Multip... Stage II Ovaria... Stage III Malig... Stage III Multi... Stage III Ovari... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Stage IV Ovaria... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Chor... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Embr... Testicular Tera... Testicular Yolk... Testicular Yolk... Testicular Yolk... | ipilimumab therapeutic all... | 18 Years - | National Cancer Institute (NCI) | |
| Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy | NCT00716976 | Brain Tumor Central Nervous... Childhood Germ ... Extragonadal Ge... Liver Cancer Neuroblastoma Ototoxicity Ovarian Cancer Sarcoma | sodium thiosulf... examination | 1 Year - 18 Years | Children's Oncology Group | |
| High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma | NCT00389766 | Neuroblastoma | iodine I 131 me... topotecan hydro... chemotherapy peripheral bloo... radioisotope th... radionuclide im... radiosensitizat... total-body irra... | 1 Year - 17 Years | National Cancer Institute (NCI) | |
| Ethanol-Lock Treatment in Preventing Central Venous Catheter Infections in Patients With High-Risk Neuroblastoma | NCT00471679 | Neuroblastoma | ethanol | - | Memorial Sloan Kettering Cancer Center | |
| Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma | NCT00005576 | Disseminated Ne... Recurrent Neuro... Regional Neurob... | monoclonal anti... isotretinoin aldesleukin sargramostim | - 21 Years | National Cancer Institute (NCI) | |
| Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors | NCT00003846 | Brain and Centr... Neuroblastoma | filgrastim carboplatin cyclophosphamid... thiotepa vincristine sul... bone marrow abl... peripheral bloo... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant | NCT00417053 | Neuroblastoma | filgrastim busulfan carboplatin cyclophosphamid... doxorubicin hyd... etoposide phosp... melphalan vincristine sul... autologous bone... bone marrow abl... conventional su... peripheral bloo... radiation thera... | - 1 Year | National Cancer Institute (NCI) | |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor | NCT00003273 | Brain and Centr... Neuroblastoma Retinoblastoma Sarcoma | filgrastim carboplatin cisplatin cyclophosphamid... etoposide leucovorin calc... methotrexate temozolomide thiotepa vincristine sul... autologous bone... peripheral bloo... radiation thera... | - 10 Years | NYU Langone Health | |
| Monoclonal Antibody 3F8 and Sargramostim in Treating Patients With Neuroblastoma | NCT00072358 | Neuroblastoma | anti-GD2 murine... anti-GD2 murine... | - | Memorial Sloan Kettering Cancer Center | |
| Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors | NCT00003846 | Brain and Centr... Neuroblastoma | filgrastim carboplatin cyclophosphamid... thiotepa vincristine sul... bone marrow abl... peripheral bloo... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
| R(+)XK469 in Treating Patients With Advanced Neuroblastoma | NCT00028522 | Disseminated Ne... Localized Unres... Recurrent Neuro... Regional Neurob... | R(+)XK469 | 5 Years - 20 Years | National Cancer Institute (NCI) | |
| Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma | NCT00960739 | Neuroblastoma | Topotecan hydro... Autologous hema... iobenguane I 13... total-body irra... | 1 Year - 20 Years | Centre Oscar Lambret | |
| Protein Expression in Human Neuroblastoma Tumor Samples | NCT01407731 | Neuroblastoma | protein express... western blottin... laboratory biom... | - | Children's Oncology Group | |
| Temozolomide in Treating Young Patients With High-Risk Relapsed or Refractory Neuroblastoma | NCT00276679 | Neuroblastoma | temozolomide | 1 Year - 16 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Followed by Surgery and Peripheral Stem Cell or Bone Marrow Transplantation in Treating Infants With Newly Diagnosed Neuroblastoma | NCT00025649 | Neuroblastoma | filgrastim busulfan carboplatin cyclophosphamid... doxorubicin hyd... etoposide melphalan vincristine sul... autologous bone... conventional su... peripheral bloo... | - 1 Year | National Cancer Institute (NCI) | |
| N99-02: Melphalan and Buthionine Sulfoximine | NCT00005835 | Neuroblastoma | buthionine sulf... melphalan Peripheral bloo... Filgrastim | - 30 Years | New Approaches to Neuroblastoma Therapy Consortium | |
| Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors | NCT00003846 | Brain and Centr... Neuroblastoma | filgrastim carboplatin cyclophosphamid... thiotepa vincristine sul... bone marrow abl... peripheral bloo... radiation thera... | 3 Years - 21 Years | Children's Oncology Group | |
| Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma | NCT00392340 | Neuroblastoma | filgrastim doxorubicin hyd... topotecan hydro... vincristine sul... | 1 Year - 20 Years | National Cancer Institute (NCI) | |
| Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer | NCT00003023 | Neuroblastoma Sarcoma | BCG vaccine monoclonal anti... | - | Memorial Sloan Kettering Cancer Center | |
| ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment | NCT00436852 | Disseminated Ne... Recurrent Neuro... | ABT-751 quality-of-life... | - 21 Years | Children's Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
